IPO-Bound PharmEasy's Unlisted Share Prices Fall 15% In A Week
The unlisted share prices of API Holdings, which owns PharmEasy, have declined in the range of 12.6%-15% in the past one week
Stay updated with breaking news from Dharmil Sheth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The unlisted share prices of API Holdings, which owns PharmEasy, have declined in the range of 12.6%-15% in the past one week
The Indian startup ecosystem reported total funding of about $724 Mn across 32 deals and 12 acquisitions between October 18 and 23.
PharmEasy has reportedly secured $350 million (~Rs. 2,600 crore) in the Pre-IPO funding round at a $5.6 billion valuation.
IPO-Bound PharmEasy which is set to file its DRHP this month has scooped up $350 Mn in a primary as well as secondary round.
API Holdings, the parent company of online pharmacy marketplace Pharmeasy is said to raise $1 Bn through its initial public offering.